Peer Review History

Original SubmissionSeptember 3, 2020
Decision Letter - Ines Alvarez-Garcia, Editor

Dear Jeff,

Thank you for submitting your manuscript entitled "Architecture of the human C9orf72-SMCR8 complex" for consideration as a Research Article by PLOS Biology.

Your manuscript has now been evaluated by the PLOS Biology editorial staff as well as by an academic editor with relevant expertise and I am writing to let you know that we would like to send your submission out for external peer review.

However, before we can send your manuscript to reviewers, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire.

Please re-submit your manuscript within two working days, i.e. by Sep 16 2020 11:59PM.

Login to Editorial Manager here: https://www.editorialmanager.com/pbiology

During resubmission, you will be invited to opt-in to posting your pre-review manuscript as a bioRxiv preprint. Visit http://journals.plos.org/plosbiology/s/preprints for full details. If you consent to posting your current manuscript as a preprint, please upload a single Preprint PDF when you re-submit.

Once your full submission is complete, your paper will undergo a series of checks in preparation for peer review. Once your manuscript has passed all checks it will be sent out for review.

Given the disruptions resulting from the ongoing COVID-19 pandemic, please expect delays in the editorial process. We apologise in advance for any inconvenience caused and will do our best to minimize impact as far as possible.

Feel free to email us at plosbiology@plos.org if you have any queries relating to your submission.

Kind regards,

Ines

--

Ines Alvarez-Garcia, PhD

Senior Editor

PLOS Biology

ialvarez-garcia@plos.org

Revision 1
Decision Letter - Ines Alvarez-Garcia, Editor

Dear Jeff,

Thank you very much for submitting your manuscript "Architecture of the human C9orf72-SMCR8 complex" for consideration as a Research Article at PLOS Biology. Thank you also for your patience as we completed our editorial process, and please accept my apologies again for the delay in providing you with our decision. Your manuscript has been evaluated by the PLOS Biology editors, an Academic Editor with relevant expertise, and by two independent reviewers.

As you will see, the reviewers agree that the structure you provide is interesting, however they also think that given the overlap with the two related publications you should compare your structure with the other two available pointing out clearly the similarities and differences. Reviewer 1 thinks you should improve the results by modelling some of the interactions described and experimentally testing one of them, and Reviewer 2 has similar thoughts and makes important requests to improve the quality of the structure analyses. In addition, the academic editor would like you to include a PDB EM Map Validation Summary Report. Please also provide accession codes for the cryo-EM reconstructions deposited into the Electron Microscopy Data Bank.

In light of the reviews (attached below), we will not be able to accept the current version of the manuscript, but we would welcome re-submission of a revised version that takes into account the reviewers' comments. We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent for further evaluation by the reviewers.

We expect to receive your revised manuscript within 3 months.

Please email us (plosbiology@plos.org) if you have any questions or concerns, or would like to request an extension. At this stage, your manuscript remains formally under active consideration at our journal; please notify us by email if you do not intend to submit a revision so that we may end consideration of the manuscript at PLOS Biology.

**IMPORTANT - SUBMITTING YOUR REVISION**

Your revisions should address the specific points made by each reviewer. Please submit the following files along with your revised manuscript:

1. A 'Response to Reviewers' file - this should detail your responses to the editorial requests, present a point-by-point response to all of the reviewers' comments, and indicate the changes made to the manuscript.

*NOTE: In your point by point response to the reviewers, please provide the full context of each review. Do not selectively quote paragraphs or sentences to reply to. The entire set of reviewer comments should be present in full and each specific point should be responded to individually, point by point.

You should also cite any additional relevant literature that has been published since the original submission and mention any additional citations in your response.

2. In addition to a clean copy of the manuscript, please also upload a 'track-changes' version of your manuscript that specifies the edits made. This should be uploaded as a "Related" file type.

3. Re-submission Checklist

When you are ready to resubmit your revised manuscript, please refer to this re-submission checklist: https://plos.io/Biology_Checklist

To submit a revised version of your manuscript, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' where you will find your submission record.

Please make sure to read the following important policies and guidelines while preparing your revision:

a) *Published Peer Review*

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/

b) *PLOS Data Policy*

Please note that as a condition of publication PLOS' data policy (http://journals.plos.org/plosbiology/s/data-availability) requires that you make available all data used to draw the conclusions arrived at in your manuscript. If you have not already done so, you must include any data used in your manuscript either in appropriate repositories, within the body of the manuscript, or as supporting information (N.B. this includes any numerical values that were used to generate graphs, histograms etc.). For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5

c) *Blot and Gel Data Policy*

We require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare them now, if you have not already uploaded them. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements

d) *Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods

e) *Blurb*

Please also provide a blurb which (if accepted) will be included in our weekly and monthly Electronic Table of Contents, sent out to readers of PLOS Biology, and may be used to promote your article in social media. The blurb should be about 30-40 words long and is subject to editorial changes. It should, without exaggeration, entice people to read your manuscript. It should not be redundant with the title and should not contain acronyms or abbreviations. For examples, view our author guidelines: https://journals.plos.org/plosbiology/s/revising-your-manuscript#loc-blurb

Thank you again for your submission to our journal. We hope that our editorial process has been constructive thus far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Best wishes,

Ines

--

Ines Alvarez-Garcia, PhD,

Senior Editor,

PLOS Biology

ialvarez-garcia@plos.org

---------------------------------------------------------------

Reviewers’ comments

Rev. 1:

In this work, Norpel and collaborators, solved the structure of the C9ORF72:SMCR8 complex by Cryo-EM. Overall, this work is well performed, clear, well written and use state if the art approaches and techniques. However, identical cryo-EM structures (PDB 6LTO and 6V4U) have been recently reported by two other groups (Tang et al., PNAS May 2020; Su et al., September 2020). Furthermore, Tang and Su studies provide additional data such as the structure of WDR41 associated to the C9:S8 complex, biochemical evidences of a GTPase activating activity for SMCR8, etc; data which are absent from the present work.

Judging the relevance for publication of a well-performed work, but that just get scooped, is always a difficult task, both for Referees and for Editors. To my personal opinion, and trying to be as fair as possible, while the cryo-EM structure of the authors is nicely done and relevant to the C9 field, there is too little novel data and information to accept this work for publication (at least in the present state). At minima, cryo-EM data should be align to 6LTO and 6V4U structures to discuss similarities and differences. Why a large part of SMCR8 (aas 400 to 700 ?) is "invisible" to cryo-EM in all three studies should be discussed. To bring some novelties, if SMCR8 is a GAP protein for ARF1 (Su et al) or RAB8 (Tang et al), maybe the authors could try to model these interaction and dock ARF1 or RAB8 proteins (for which structure are available) in their C9:S8 model. Furthermore, the proposed hypothesis of an interaction between SMCR8 usent alpha helixes with the coil coil domain of FIP200 (RB1CC1) should not be stated without being experimentally tested.

Rev. 2:

The authors determined the human C9ORF72-SMCR8 complex by cryo-EM single particle method and identified the coiled-coil region of SMCR8 which acts as an interaction platform for FIP200. There are several problems which should be further clarified before its publication.

Major point:

a, The C9ORF72-SMCR8-WDR41 trimeric complex has been solved at 3.2 Å and 3.8 Å by Qi's and Hurley's group, the authors failed mention those important progress. Does the C9ORF72-SMCR8 dimer has any structural difference with C9ORF72-SMCR8-WDR41 complex?

b, Description for the process of model building is not clear. 3.8 Å resolution of cryo-EM map is difficult for de-novo model building, were there any coordinates served as the initial model? Density map figures for residues in the best region should be provided to help the audiences ensure the residues assignment.

c, Description for the cryo-EM data processing is not clear, and the cryo-EM map seems problematic. The cryo-EM map in the figure seems weird, not reach 3.8 Å and suffers from overfitting. Local resolution map in Figure S2F shows most region reach 3 Å, but actually is not. Does any improvement after focus refinement at small region in the Figure S2?

Minor points:

a, model validation curves should be provided for all complexed.

b, Contents of Table S1 has serval errors. For example, Final particle numbers and B-factors (Lower resolution usually has a larger B-factor, 4.4 Å resolution is around -200 ). Clash score is higher, the model should be further improved. Molprobility Score should be provided.

Attachments
Attachment
Submitted filename: Comments.docx
Revision 2

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Ines Alvarez-Garcia, Editor

Dear Jeff,

Thank you for submitting your revised Research Article entitled "Architecture of the human C9orf72-SMCR8 complex" for publication in PLOS Biology. I have now obtained advice from one of the original reviewers and have discussed these comments with the Academic Editor, who has also checked your responses to the other reviewer's comments.

Based on the reviews, we will probably accept this manuscript for publication, provided you satisfactorily address the remaining points raised by Reviewer 1 (see below). Please also make sure to address the data and other policy-related requests included in the letter. In addition, we would like you to improve the title to be more informative, as this is not the first structure of this complex and its overall architecture is already known. Please use the following template, in which XXX are the main conclusions of your work that add to previous work. Perhaps that it is probably a GAP and it probably acts as a platform for binding something else with coiled coils, for example?

"Architecture of the human C9orf72-SMCR8 complex reveals XXX"

As you address these items, please take this last chance to review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the cover letter that accompanies your revised manuscript.

We expect to receive your revised manuscript within two weeks.

To submit your revision, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' to find your submission record. Your revised submission must include the following:

- a cover letter that should detail your responses to any editorial requests, if applicable, and whether changes have been made to the reference list

- a Response to Reviewers file that provides a detailed response to the reviewers' comments (if applicable)

- a track-changes file indicating any changes that you have made to the manuscript.

NOTE: If Supporting Information files are included with your article, note that these are not copyedited and will be published as they are submitted. Please ensure that these files are legible and of high quality (at least 300 dpi) in an easily accessible file format. For this reason, please be aware that any references listed in an SI file will not be indexed. For more information, see our Supporting Information guidelines:

https://journals.plos.org/plosbiology/s/supporting-information

*Published Peer Review History*

Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/

*Early Version*

Please note that an uncorrected proof of your manuscript will be published online ahead of the final version, unless you opted out when submitting your manuscript. If, for any reason, you do not want an earlier version of your manuscript published online, uncheck the box. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us as soon as possible if you or your institution is planning to press release the article.

*Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please do not hesitate to contact me should you have any questions.

Sincerely,

Ines

--

Ines Alvarez-Garcia, PhD,

Senior Editor,

ialvarez-garcia@plos.org,

PLOS Biology

------------------------------------------------------------------------

DATA POLICY: IMPORTANT - PLEASE READ

You may be aware of the PLOS Data Policy, which requires that all data be made available without restriction: http://journals.plos.org/plosbiology/s/data-availability. For more information, please also see this editorial: http://dx.doi.org/10.1371/journal.pbio.1001797

Note that we do not require all raw data. Rather, we ask that all individual quantitative observations that underlie the data summarized in the figures and results of your paper be made available in one of the following forms:

1) Supplementary files (e.g., excel). Please ensure that all data files are uploaded as 'Supporting Information' and are invariably referred to (in the manuscript, figure legends, and the Description field when uploading your files) using the following format verbatim: S1 Data, S2 Data, etc. Multiple panels of a single or even several figures can be included as multiple sheets in one excel file that is saved using exactly the following convention: S1_Data.xlsx (using an underscore).

2) Deposition in a publicly available repository. Please also provide the accession code or a reviewer link so that we may view your data before publication.

Regardless of the method selected, please ensure that you provide the individual numerical values that underlie the summary data displayed in the following figure panels as they are essential for readers to assess your analysis and to reproduce it:

Fig. 5D-E; Fig. S2D and Fig. S10

NOTE: the numerical data provided should include all replicates AND the way in which the plotted mean and errors were derived (it should not present only the mean/average values).

- Please also ensure that figure legends in your manuscript include information on WHERE THE UNDERLYING DATA CAN BE FOUND, and ensure your supplemental data file/s has a legend.

- Please also make sure the data that you have deposited in the Electron Microscopy Data Bank and Protein Data Bank with accession numbers EMD-12700 and 7O2W, respectively, is made publicly available at this time.

------------------------------------------------------------------------

Reviewers' comments

Rev. 1:

The authors adequally addressed my comments.

As a minor point, modelisation of the C9 complex with an ARF (ARF1 ? ARF6 ?) versus RAB8 could have been presented and discussed as both RAB8 and ARF proteins were found as potential interactants / targets of this complex, etc.

Revision 3

Attachments
Attachment
Submitted filename: Response-to-reviewers.docx
Decision Letter - Ines Alvarez-Garcia, Editor

Dear Jeff,

On behalf of my colleagues and the Academic Editor, Kylie Walters, I am pleased to say that we can in principle offer to publish your Research Article "Structure of the human C9orf72-SMCR8 complex reveals a multivalent protein-interaction architecture" in PLOS Biology, provided you address any remaining formatting and reporting issues. These will be detailed in an email that will follow this letter and that you will usually receive within 2-3 business days, during which time no action is required from you. Please note that we will not be able to formally accept your manuscript and schedule it for publication until you have made the required changes.

Thanks for the update regarding the data deposited at PDB, however please note that until the data deposited in both Electron Microscopy Data Bank (EMD-12700) and Protein Data Bank (7O2W) are publicly available we won't be able to accept the manuscript for production.

Please take a minute to log into Editorial Manager at http://www.editorialmanager.com/pbiology/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production process.

PRESS

We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with biologypress@plos.org. If you have not yet opted out of the early version process, we ask that you notify us immediately of any press plans so that we may do so on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit http://www.plos.org/about/media-inquiries/embargo-policy/.

Thank you again for choosing PLOS Biology for publication and supporting Open Access publishing. We look forward to publishing your study. 

Sincerely, 

Ines

--

Ines Alvarez-Garcia, PhD 

Senior Editor 

PLOS Biology

ialvarez-garcia@plos.org

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .